Keyphrases
Breast Cancer Subtypes
100%
Adrenergic System
100%
Adrenergic Agents
100%
Breast Cancer
100%
Breast Cancer Cells
100%
Opioidergic
100%
Opioidergic System
100%
β-endorphin
66%
δ Opioid Receptor
66%
Tumor Cells
66%
Xenograft
66%
Tumor Microenvironment
66%
β2-Adrenergic Receptor (β2AR)
66%
Cellular Physiology
66%
Cell Therapy
66%
Cancer Cell Growth
33%
Proliferation Apoptosis
33%
Biochemical Signaling
33%
Immune Cell Function
33%
Cancer Growth
33%
Inflammatory Conditions
33%
Biochemical Markers
33%
Breast Tumor
33%
Cell Progression
33%
Combined Treatment
33%
Signaling Molecules
33%
Molecular Approaches
33%
HER2+
33%
Pharmacological Agents
33%
Mammary Tumor
33%
Beneficial Effects
33%
Immune Cells
33%
Human Epidermal Growth Factor Receptor 2 (HER2)
33%
Epithelial-mesenchymal Transition
33%
Marker Compounds
33%
Tumor Incidence
33%
Simultaneous Activation
33%
Adrenergic Receptor Antagonist
33%
Growth Prevention
33%
Prevalence Rate
33%
Adrenergic alpha-antagonists
33%
Breast Tumor Cells
33%
Athymic nude Rat
33%
Rat Animal Model
33%
Basal-like Tumors
33%
Immune Response
33%
Immune Function
33%
Cellular Approach
33%
Basal-like
33%
Carcinogen-induced
33%
Molecular Action
33%
Effective Therapy
33%
Human Tumor Tissue
33%
Breast Cancer Cell Lines
33%
Triple Negative
33%
Body Stress
33%
Metastasis
33%
Prognostic Factors
33%
Gene Knockout
33%
Luminal B
33%
Receptor Dimerization
33%
Malignancy Rate
33%
Molecular Subtypes
33%
Opioid Agonist
33%
Humanized NSG Mice
33%
Invasiveness
33%
Medicine and Dentistry
Adrenergic System
100%
Breast Cancer
100%
Breast Tumor
57%
Neoplasm
57%
Sympathomimetic Drug
42%
Cell Function
42%
Cancer Cell
28%
Tumor Microenvironment
28%
Cell Therapy
28%
Cancer Growth
28%
Adrenergic Receptor Blocking Agent
28%
Immunocompetent Cell
28%
Beta 2 Adrenergic Receptor
28%
Xenograft
28%
Endorphin
28%
Tumor Cell
14%
Receptor
14%
Carcinogen
14%
Cancer
14%
Serositis
14%
Signaling Molecule
14%
Prevalence
14%
Immune Response
14%
Delta Opiate Receptor Agonist
14%
Biochemical Marker
14%
Mesenchymal-Epithelial Transition
14%
Opiate Agonist
14%
Gene Knockdown
14%
Breast Cancer Cell Line
14%
Metastatic Carcinoma
14%
Prognostic Factor
14%
Programmed Cell Death
14%
Immunity
14%
Delta Opiate Receptor
14%